Literature DB >> 3107725

Remission of symptoms in carcinoid syndrome with a new 5-hydroxytryptamine M receptor antagonist.

J V Anderson, M O Coupe, J A Morris, H J Hodgson, S R Bloom.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3107725      PMCID： PMC1246289          DOI： 10.1136/bmj.294.6580.1129

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  2 in total

1.  Management of carcinoid tumors of the gastrointestinal tract.

Authors:  J P Welch; R A Malt
Journal:  Surg Gynecol Obstet       Date:  1977-08

2.  Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs.

Authors:  B P Richardson; G Engel; P Donatsch; P A Stadler
Journal:  Nature       Date:  1985 Jul 11-17       Impact factor: 49.962
  2 in total
  14 in total

1.  Cisplatin impairs fluid and electrolyte absorption in rat small intestine: a role for 5-hydroxytryptamine.

Authors:  C P Bearcroft; P Domizio; F H Mourad; E A André; M J Farthing
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

Review 2.  5-HT3 receptor antagonists. An overview of their present status and future potential in cancer therapy-induced emesis.

Authors:  M S Aapro
Journal:  Drugs       Date:  1991-10       Impact factor: 9.546

3.  Effects of a 5-hydroxytryptamine3 receptor antagonist (ICS 205-930) on colonic motor activity in healthy men.

Authors:  G Stacher; G Gaupmann; C Schneider; G Stacher-Janotta; G Steiner-Mittelbach; T A Abatzi; H Steinringer
Journal:  Br J Clin Pharmacol       Date:  1989-09       Impact factor: 4.335

4.  Adrenergic modulation of the release of 5-hydroxytryptamine from the vascularly perfused ileum of the guinea-pig.

Authors:  K Racké; H Schwörer; H Kilbinger
Journal:  Br J Pharmacol       Date:  1988-11       Impact factor: 8.739

5.  Effect of ICS 205-930 (a specific 5-HT3 receptor antagonist) on gastric emptying of a solid meal in normal subjects.

Authors:  L M Akkermans; A Vos; A Hoekstra; J M Roelofs; M Horowitz
Journal:  Gut       Date:  1988-09       Impact factor: 23.059

6.  Effects of the 5-HT3 receptor antagonist ICS 205-930 on fat-delayed gastric emptying and antral motor activity.

Authors:  G Stacher; H Bergmann; C Schneider; G Steiner-Mittelbach; G Gaupmann; H Steinringer; T A Abatzi; G Stacher-Janotta
Journal:  Br J Clin Pharmacol       Date:  1990-07       Impact factor: 4.335

7.  Effects of the 5-HT3 antagonist cilansetron vs placebo on phasic sigmoid colonic motility in healthy man: a double-blind crossover trial.

Authors:  G Stacher; U Weber; G Stacher-Janotta; P Bauer; K Huber; A Holzäpfel; G Krause; C Steinborn
Journal:  Br J Clin Pharmacol       Date:  2000-05       Impact factor: 4.335

8.  Effects of serotonin on rat ileocolonic transit and fluid transfer in vivo: possible mechanisms of action.

Authors:  L Oosterbosch; M von der Ohe; M A Valdovinos; L J Kost; S F Phillips; M Camilleri
Journal:  Gut       Date:  1993-06       Impact factor: 23.059

9.  Failure of tropisetron to inhibit jejunal water and electrolyte secretion induced by 5-hydroxytryptamine in healthy volunteers.

Authors:  L K Munck; O Eskerod; M B Hansen; K Bukhave; J Rask-Madsen
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

Review 10.  Tropisetron. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential as an antiemetic.

Authors:  C R Lee; G L Plosker; D McTavish
Journal:  Drugs       Date:  1993-11       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.